As Gavi marks its twentieth anniversary, a new report from the ABPI and IFPMA looks at the past successes of the Vaccines Alliance and what the future holds. Richard Torbett looks ahead to that commitment to protect future generations from infectious diseases.
On International Clinical Trials Day, Dr Sheuli Porkess considers the impact that COVID-19 is having on clinical trials and the potential lessons for the future research.
Malcolm Skingle CBE PhD, Chair of the ABPI's ACES Strategic Leadership Group, looks at the data from our most recent survey of academic-industry links.
COVID-19 has emerged as a brand new disease with a severe impact on patients, the public and health systems around the world.
The balance the Chancellor needs to strike in delivering his first Budget on Wednesday has been made even tougher by the need to prioritise measures to tackle coronavirus.
Our President Haseeb Ahmad sets out how industry is working to find treatments and cures for some of the world’s most complex diseases. Nowhere is the need to find new medicines more acute than in rare diseases, many of which are genetic and affect the youngest patients.
We spoke to Dr Lucy McKay, CEO of the charity Medics4RareDiseases. She told us why health professionals should ‘dare to think rare’ in their patients.
Prabhjot is a is a university lecturer in living in London. She describes her experience of living with polymyositis.
Karen Owen lives with a condition called hereditary angioedema (HAE). She has learned to take control of HAE through self-management techniques and peer support.
February is Raynaud’s awareness month. Physiotherapist and Parkinson’s dance teacher Liz Hooks has the condition and for her, a little kindness and the offer of some hot water would go a long way to help manage it.